Close Menu

Amgen

Movers & Shakers

Premium

Quanterix this week appointed Martin Madaus as CEO. Madaus had been serving as the company's acting CEO and chairman of the board of directors, a position that he will retain.

Originally published August 18.
By Turna Ray

Advanced sequencing technologies are great for discovery, but not ready to be incorporated into Qiagen's commercial companion diagnostics portfolio, according to CEO Peer Schatz.

"Courts are willing to require the use and understanding of genetic information even before the medical community itself is ready and able to do so," according to researchers from Arizona State University who are tracking increasing liability risk for doctors within the context of genomic medicine.

EGFR has emerged as a primary area of interest in cancer research, with biopharmaceuticals like Imclone's Erbitux and Amgen's Vectibix targeting the protein, but its multiple isoforms have made it difficult to predict these drugs' effectiveness, said Yale professor Nita Maihle.

"We are always looking at entities, particularly DTC companies, who may be marketing APOE tests without a sublicense from Athena, are making misleading representations of those tests and their clinical interpretations, and are generally violating patent claims we own and have licensed, accordingly," said a Duke spokesperson.

The "opt-in" model ensures that customers are aware of the risks and limitations of this potentially sensitive data, but some are questioning whether the direct-to-consumer model is the appropriate mechanism for delivering information on APOE status, even with additional precautions.

A Cleveland Clinic official recently discussed three investigations that have added to the body of knowledge about how genomic medicine should be adopted into the existing healthcare infrastructure.

The Government Accountability Office squelched a rumor that has been circulating about the firing of an agency investigator due to errors in a report on for-profit colleges. Additionally, the agency said it has not "identified any problems" with a report on the DTC genomics industry that was led by the same investigator.

The Molecular and Clinical Genetics Panel held a public meeting this week to discuss potential strategies for regulating some DTC genetic tests.

Pages

The Associated Press reports that a state board in Texas has asked ANDE, a maker of rapid DNA machines, to halt its work there.

James Wyngaarden, the former director of the US National Institutes of Health, has died at 94, according to Duke University School of Medicine.

Researchers find that a 30-year-old skull comes from a narwhal-beluga hybrid, according to Science News.

In Nature this week: study of value diversity in GWAS, Epstein-Barr virus subtypes linked to nasopharyngeal carcinoma risk, and more.